X4 Pharmaceuticals (XFOR) Debt Metrics
Market Cap: $33.00M
Avg Volume: 110.22K
Industry: Biotechnology
Sector: Healthcare
How much debt does X4 Pharmaceuticals have?
According to X4 Pharmaceuticals's latest annual financial reports, the company's debt profile is as follows:
Total Debt and Liabilities
X4 Pharmaceuticals's total debt stands at $2.66M. This is broken down into:
- Long-term debt: $2.82M
- Short-term debt: $1.25M
The company's net debt, which accounts for cash and cash equivalents, is $-53.04M. In terms of overall financial obligations, X4 Pharmaceuticals's total liabilities amount to $124.30M.
Debt Ratios and Metrics
To better understand X4 Pharmaceuticals's debt position, we can look at several key ratios:
- Debt to Equity Ratio: 0.12 - this indicates the proportion of equity and debt the company uses to finance its assets.
- Debt Ratio: 1.82% - this shows the proportion of a company's assets that are financed through debt.
- Interest Coverage Ratio: -4.15 - this measures how easily a company can pay interest on its outstanding debt.
- Long-term Debt to Capitalization: 5.98% - this shows the proportion of long-term debt in the company's capital structure.
- Total Debt to Capitalization: 10.73% - this indicates the total debt in the company's capital structure.
These metrics provide insight into X4 Pharmaceuticals's financial leverage and its ability to meet financial obligations. For a comprehensive understanding of the company's financial health, it's important to consider these debt metrics alongside other financial indicators and industry benchmarks.
Total Debt
$2.66M
Long-term Debt
$2.82M
Short-term Debt
$1.25M
Net Debt
$-53.04M
Total Liabilities
$124.30M
Interest Coverage
-4.15
Debt to Equity Ratio
0.12
Debt Ratio
1.82%
X4 Pharmaceuticals Historical Debt Metrics
X4 Pharmaceuticals Historical Debt
The table below shows various debt metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Total Debt | Long-term Debt | Short-term Debt | Net Debt | Total Liabilities | Debt to Equity | Debt Ratio | Interest Coverage | Long-term Debt to Capitalization | Total Debt to Capitalization |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $2.66M | $2.82M | $1.25M | $-53.04M | $124.30M | 0.12 | 1.82% | -4.15 | 5.98% | 10.73% |
| 2023 | $58.28M | $57.18M | $1.10M | $-40.94M | $96.16M | 1.14 | 39.58% | -18.61 | 51.64% | 53.28% |
| 2022 | $38.42M | $35.91M | $3.71M | $-83.30M | $81.53M | 0.52 | 24.69% | -21.93 | 30.37% | 34.16% |
| 2021 | $39.78M | $37.91M | $2.94M | $-42.00M | $52.76M | 0.62 | 33.95% | -23.37 | 33.97% | 38.18% |
| 2020 | $38.45M | $37.66M | $1.57M | $-40.26M | $50.07M | 0.53 | 31.29% | -22.27 | 31.31% | 34.56% |
| 2019 | $22.91M | $22.02M | $1.80M | $-103.27M | $31.48M | 0.18 | 14.26% | -24.08 | 13.46% | 15.06% |
| 2018 | $7.89M | $7.89M | $1.69M | $-22.86M | $14.40M | 0.37 | 21.93% | -44.16 | 26.76% | 26.76% |
| 2017 | $12.24M | $9.92M | $2.31M | $-64.56M | $22.55M | 0.21 | 15.06% | -17.38 | 14.46% | 17.25% |
| 2016 | $15.29M | $-29.71M | $3.49M | $12.25M | $64.17M | -0.27 | 201.07% | -9.68 | -21.81% | -37.04% |
| 2015 | $7.19M | $-25.24M | $2.07M | $435.00K | $43.83M | -0.21 | 75.65% | -31.41 | -15.88% | -26.52% |
Related Metrics
Explore detailed financial metrics and analysis for XFOR.